Detection of induced resistance to cytosine-arabinoside with a short-term test.

M. Volm,E. Maas,J. Mattern

DOI: https://doi.org/10.1016/0014-2964(80)90216-9

IF: 10.002

1980-05-01

European Journal of Cancer

Abstract:

What problem does this paper attempt to address?

Association Between Migraine or Severe Headache and Hypertension among US Adults: A Cross-Sectional Study

Jing Zhang,Yukang Mao,Yansong Li,Kun Zhao,Qiyang Xie,Kai Wang,Jing Shi

DOI: https://doi.org/10.1016/j.numecd.2022.11.014

IF: 4.666

2023-01-01

Nutrition Metabolism and Cardiovascular Diseases

Abstract:Background and aims: Epidemiological evidence of the association between migraines, severe headaches, and hypertension is contradictory. Hypertension is a critical risk factor for car-diovascular diseases. Migraine is a common neurological disease and a major cause of disability worldwide. Therefore, we aimed to investigate the relationship between migraine, severe head-aches, and hypertension among US adults.Methods and results: Cross-sectional data from 5716 subjects were obtained from the National Health and Nutrition Examination Survey between 1999 and 2004. Weighted logistic regression models investigated the association between migraines, severe headaches, and hypertension. In total, 5716 subjects were enrolled in the present study, of whom 1134 (19.8%) had migraine or severe headaches. Participants with migraine were predominantly younger females and had a higher body mass index (BMI), lower educational level, lower dietary intake of potassium and calcium, lower serum levels of total cholesterol (TC), creatinine, and hemoglobin, as well as a higher estimated glomerular filtration rate (eGFR) (all P < 0.05). After fully adjusting for potential confounders, migraine or severe headaches were positively associated with hypertension (OR 1.25, 95% CI: 1.03-1.53).Conclusion: Our study found a positive association between migraine, severe headaches, and hy-pertension. Further studies are needed to verify the causality of this association and elucidate the underlying mechanisms.& COPY; 2022 The Italian Diabetes Society, the Italian Society for the Study of Atherosclerosis, the Ital-ian Society of Human Nutrition and the Department of Clinical Medicine and Surgery, Federico II University. Published by Elsevier B.V. All rights reserved.
Risk for Ischemic Stroke and Coronary Heart Disease Associated with Migraine and Migraine Medication among Older Adults

McKinley Emily C.,Lay Christine L.,Rosenson Robert S.,Chen Ligong,Chia Victoria,Colantonio Lisandro D.,Muntner Paul,Urman Robert,Farkouh Michael E.

DOI: https://doi.org/10.1186/s10194-021-01338-z

2021-01-01

The Journal of Headache and Pain

Abstract:Abstract Background Migraine has been associated with cardiovascular disease (CVD) events among middle-aged adults. The objective of this study was to determine the risk for ischemic stroke and coronary heart disease (CHD) events among older adults with versus without migraine. Methods This retrospective cohort study was conducted using data from US adults ≥66 years of age with Medicare health insurance between 2008 and 2017. After stratification by history of CVD, patients with a history of migraine were matched 1:4 to those without a history of migraine, based on calendar year, age, and sex. Patients were followed through December 31, 2017 for ischemic stroke and CHD events including myocardial infarction or coronary revascularization. All analyses were done separately for patients with and without a history of CVD. Results Among patients without a history of CVD (n = 109,950 including n = 21,990 with migraine and n = 87,960 without migraine), 1789 had an ischemic stroke and 3552 had a CHD event. The adjusted hazard ratio (HR) among patients with versus without migraine was 1.20 (95% confidence interval [95%CI], 1.07–1.35) for ischemic stroke and 1.02 (95%CI, 0.93–1.11) for CHD events. Compared to patients without migraine, those with migraine who were taking an opioid medication had a higher risk for ischemic stroke (adjusted HR 1.43 [95%CI, 1.20–1.69]), while those taking a triptan had a lower risk for CHD events (adjusted HR 0.79 [95%CI, 0.67–0.93]). Among patients with a history of CVD (n = 79,515 including n = 15,903 with migraine and n = 63,612 without migraine), 2960 had an ischemic stroke and 7981 had a CHD event. The adjusted HRs (95%CI) for ischemic stroke and CHD events associated with migraine were 1.27 (1.17–1.39) and 0.99 (0.93–1.05), respectively. Patients with migraine taking an opioid medication had a higher risk for ischemic stroke (adjusted HR 1.21 [95%CI, 1.07–1.36]), while those taking a triptan had a lower risk for CHD events (adjusted HR 0.83 [95%CI, 0.72–0.95]), each versus those without migraine. Conclusions Older adults with migraine are at increased risk for ischemic stroke. The risk for ischemic stroke among older adults with migraine may differ by migraine medication classes.
Frontometaphyseal dysplasia: symptoms and possible mode of inheritance.

I. Jend-Rossmann,H. Jend,J. Ringe,K. Gundlach

DOI: https://doi.org/10.1016/0278-2391(84)90425-7

IF: 1.9

1984-11-01

Journal of Oral and Maxillofacial Surgery

Abstract:
Cerebrovascular Function in Hormonal Migraine: An Exploratory Study

Jemima S A Dzator,Peter R C Howe,Lyn R Griffiths,Kirsten G Coupland,Rachel H X Wong

DOI: https://doi.org/10.3389/fneur.2021.694980

2021-07-07

Abstract:Background: Migraineurs, particularly young premenopausal women, are at increased risk of cerebrovascular disease; however, there is currently limited evidence as to whether hormonal migraine is associated with poor cerebrovascular function. Objectives: The objectives of this study were to: (1) investigate the potential association of cerebrovascular function with hormonal migraine and (2) determine whether abnormalities of cerebrovascular function in hormonal migraineurs are associated with migraine-related disability and/or quality of life. Method: A cross-sectional study was undertaken in 50 hormonal migraineurs (mean age: 38.7 ± 1.2 years) and 29 controls (mean age: 35.6 ± 1.8 years). Data were collected at a single point in time from all participants during the inter-ictal period when they were free from migraine and not menstruating. Transcranial Doppler ultrasound was used to measure resting blood flow velocity and cerebrovascular responsiveness (CVR) to hypercapnia and cognitive stimulation (neurovascular coupling) in the left and right middle cerebral artery (MCA). Additionally, hormonal migraineurs completed three questionnaires to assess migraine-related disability and quality of life as well as migraine frequency and intensity: Headache Impact Test-6™, Migraine-Specific Quality of Life and Migraine Disability Assessment. Results: Hormonal migraineurs had lower resting mean blood flow velocity (MBFV) (P = 0.009) and neurovascular coupling during cognitive stimulation (P = 0.010) in the left MCA than controls. No such differences were found in the right MCA. Additionally, heart rate (P = 0.004) was higher in hormonal migraineurs than controls. However, no differences in CVR to hypercapnia were found between hormonal migraineurs and controls. Multi-variate analysis revealed age to be a significant (P = 0.012) predictor of MBFV in the left MCA. Negative correlations between headache frequency and CVR to hypercapnia in the left (P = 0.026) and right MCA (P = 0.044) were found. Additionally, negative correlations between neurovascular coupling during the 2-Back 1.5 s task in the right MCA and the MSQoL emotional (P = 0.013) and role-function restrictive (P = 0.039) domains were found. Conclusions: This is the first study to show that hormonal migraineurs have poorer cerebrovascular function, as represented by lower resting MBFV and impaired neurovascular coupling in the left MCA. Future studies should investigate whether improving cerebrovascular function can prevent hormonal migraine and improve quality of life. Clinical Trial Registration: ACTRN12618001230246.
Effects of different endurance exercise modalities on migraine days and cerebrovascular health in episodic migraineurs: A randomized controlled trial

H. Hanssen,A. Minghetti,S. Magon,A. Rossmeissl,M. Rasenack,A. Papadopoulou,C. Klenk,O. Faude,L. Zahner,T. Sprenger,L. Donath

DOI: https://doi.org/10.1111/sms.13023

2018-01-08

Scandinavian Journal of Medicine and Science in Sports

Abstract:Aerobic exercise training is a promising complementary treatment option in migraine and can reduce migraine days and improve retinal microvascular function. Our aim was to elucidate whether different aerobic exercise programs at high vs moderate intensities distinctly affect migraine days as primary outcome and retinal vessel parameters as a secondary. In this randomized controlled trial, migraine days were recorded by a validated migraine diary in 45 migraineurs of which 36 (female: 28; age: 36 (SD:10)/BMI: 23.1 (5.3) completed the training period (dropout: 20%). Participants were assigned (Strata: age, gender, fitness and migraine symptomatology) to either high intensity interval training (HIT), moderate continuous training (MCT), or a control group (CON). Intervention groups trained twice a week over a 12-week intervention period. Static retinal vessel analysis, central retinal arteriolar (CRAE) and venular (CRVE) diameters, as well as the arteriolar-to-venular diameter ratio (AVR) were obtained for cerebrovascular health assessment. Incremental treadmill testing yielded maximal and submaximal fitness parameters. Overall, moderate migraine day reductions were observed (ηP2 = .12): HIT revealed 89% likely beneficial effects (SMD = 1.05) compared to MCT (SMD = 0.50) and CON (SMD = 0.59). Very large intervention effects on AVR improvement (ηP2 = 0.27), slightly favoring HIT (SMD=-0.43) over CON (SMD=0), were observed. HIT seems more effective for migraine day reduction and improvement of cerebrovascular health compared to MCT. Intermittent exercise programs of higher intensities may need to be considered as an additional treatment option in migraine patients.

sport sciences
Association of Migraine With Incident Hypertension After Menopause: A Longitudinal Cohort Study

Conor James MacDonald,Douae El Fatouhi,Anne-Laure Madika,Guy Fagherazzi,Tobias Kurth,Gianluca Severi,Marie-Christine Boutron-Ruault

DOI: https://doi.org/10.1212/WNL.0000000000011986

IF: 9.9

2021-07-06

Neurology

Abstract:Objective: Migraine has been identified as a potential risk factor for hypertension in prospective studies. In women, migraine prevalence decreases after menopause, but no studies have determined whether migraine is associated with hypertension after menopause. This study sought to determine whether history of migraine was associated with an increased risk of hypertension among menopausal women. Methods: We assessed associations between migraine and hypertension in a longitudinal cohort study of 56,202 menopausal women participating in the French E3N cohort, with follow-up beginning in 1993. We included women who did not have hypertension or cardiovascular disease at the time of menopause. Migraine was classified as ever or never at each questionnaire cycle. Cox proportional hazards models were used to investigate relations between migraine and hypertension, controlling for potential confounding. A secondary analysis with baseline in 2011 considered aura status, grouping participants reporting migraine as migraine with aura, migraine without aura, or unknown migraine type. Results: During 826,419 person-years, 12,501 cases of incident hypertension were identified, including 3,100 among women with migraine and 9,401 among women without migraine. Migraine was associated with an increased risk of hypertension in menopausal women (hazard ratio [HR]migraine 1.29 [95% confidence interval 1.24, 1.35]) and was consistent in post hoc sensitivity analyses, such as when controlling for common migraine medications. Associations between migraine and hypertension were similar whether or not women reported aura (HRmigraine aura 1.54 [1.04, 2.30], HRmigraine no aura 1.32 [0.87, 2.02], p heterogeneity 0.60). Associations were slightly stronger among ever users of menopausal hormone therapy (HRmigraine 1.34 [1.27, 1.41]) than among never users (HRmigraine 1.19 [1.11, 1.28]). Conclusions: Migraine was associated with an increased risk of hypertension among menopausal women. In secondary analysis, we did not observe a significant difference between migraine with aura and migraine without aura.
Abstract WP252: MARS: Migraine and Retinal Stroke - A Population-Based Cohort Study of 39 Million Patients

Jay B Lusk,Ailin Song,Shakthi Unnithan,Hussein Al-Khalidi,Adam H de Havenon,Valerie Biousse,Matthew Schrag,Sven Poli,Nosayaba Osazuwa-Peters,Ying Xian,Emily C Obrien,Brian C Mac Grory

DOI: https://doi.org/10.1161/str.55.suppl_1.wp252

IF: 10.17

2024-02-03

Stroke

Abstract:Stroke, Volume 55, Issue Suppl_1, Page AWP252-AWP252, February 1, 2024. Introduction:Migraine is a risk factor for cerebral ischemic stroke. However, it is not known if migraine is a risk factor for retinal stroke (central retinal artery occlusion, CRAO).Methods:We performed a retrospective cohort study using population-based data from the State Inpatient Databases and State Emergency Department Databases from New York (2006-2015), California (2003-2011), and Florida (2005-2015) to determine the association between hospital-documented migraine and retinal stroke. The primary exposure was hospital-documented migraine. The primary endpoint was hospital-documented CRAO (ICD-9-CM code 362.31 in the primary diagnosis position) and secondary endpoints included BRAO and any retinal artery occlusion (RAO). Cause-specific hazard models were used to model the association between migraine and CRAO.Results:Of 39,835,024 patients included in the study, 1,109,140 had migraine documented during the exposure window. Patients with migraine were younger (40.2±15.2 vs. 46.9±19.8, standardized difference (SD) 0.38), more likely to be female (81.4% vs. 54.7%, SD 0.6), and had a lower burden of atrial fibrillation (4.5% vs. 6.9%, SD 0.1), chronic kidney disease (1.9% vs. 3.6%, SD 0.2), and congestive cardiac failure (2.7% vs. 5.1%, SD 0.12). Migraine was not associated with CRAO in the primary diagnostic position (adjusted hazard rate (aHR) 1.15 (95% CI: 0.79-1.67). However, it was associated with CRAO in any diagnostic position (aHR 1.39 (95% CI: 1.08-1.78). As positive controls, we replicated previously established associations of migraine with cerebral ischemic stroke (aHR 1.35 (95% CI: 1.32-1.38) and embolic ischemic stroke (aHR 1.15 (95% CI: 1.08-1.22).Conclusions:In a large, claims-based study, we found a risk-adjusted association between migraine and CRAO considered in any diagnostic position. This finding sets the stage for future work leveraging both outpatient and pharmacy-based claims to further explore this finding.

peripheral vascular disease,clinical neurology
Migraine and Risk of Parkinson Disease in Women: A Cohort Study

Ricarda S Schulz,Toivo Glatz,Julie E Buring,Pamela M Rist,Tobias Kurth

DOI: https://doi.org/10.1212/WNL.0000000000209747

IF: 9.9

2024-09-24

Neurology

Abstract:Background and objectives: Migraine and Parkinson disease (PD) are common neurologic disorders, which are hypothesized to share some pathophysiologic mechanisms. However, data on the association between migraine and risk of developing PD are sparse. We estimate the effect of migraine, migraine subtypes, and migraine episode frequency on the risk of developing PD in middle-aged and older women. Methods: We used data from the Women's Health Study, a United States-based cohort of women in health professions aged 45 years and older at baseline (1992-1995). Only women with complete self-reported information on migraine and headache and no history of PD were included. Participants were followed up for self-reported physician-diagnosed PD through December 31, 2021. We used multivariable Cox proportional hazards models to estimate hazard ratios (HRs) and corresponding 95% CIs of the association between migraine, migraine subtypes, and migraine episode frequency and the risk of developing PD. Results: A total of 39,312 women were included in the analyses. Among those, 7,321 women (18.6%) reported any migraine at baseline, of whom 2,153 (5.5%) reported a history of migraine, 2,057 (5.2%) reported migraine with aura, and 3,111 (7.9%) reported migraine without aura. During a mean follow-up of 22.0 years, 685 PD cases were reported. Of those, 128 (18.7%) were reported by women who also reported any migraine and 557 (81.3%) by women without any migraine. After adjusting for confounding, the HR for the association of any migraine on the risk of PD was 1.07 (0.88-1.29). Compared with women without migraine, the HRs (95% CI) for PD were 0.87 (0.59-1.27) for migraine with aura, 1.21 (0.93-1.58) for migraine without aura, and 1.05 (0.76-1.45) for history of migraine. Compared with those with a migraine frequency of less than monthly, the HRs were 1.09 (0.64-1.87) for a monthly frequency and 1.10 (0.44-2.75) for a weekly or greater frequency. Discussion: In this large cohort of women, the risk of developing PD was not elevated among those experiencing migraine, irrespective of migraine subtypes or the frequency of migraine. The generalizability of our findings to other populations, such as men, should be further investigated. Trial registration information: ClinicalTrials.gov Identifier: NCT00000479.
Autonomic symptoms in migraine: Results of a prospective longitudinal study

Jason C. Ray,Sanjay Cheema,Emma Foster,Lakshini Gunasekera,Dwij Mehta,Susan J. Corcoran,Manjit S. Matharu,Elspeth J. Hutton

DOI: https://doi.org/10.3389/fneur.2022.1036798

IF: 3.4

2022-11-04

Frontiers in Neurology

Abstract:Objective: To assess the prevalence and burden of autonomic symptoms in migraine, and determine the relationship with migraine frequency. Background: Autonomic symptoms in migraine have been theorized to occur in the setting of inter-ictal sympathetic hypoactivity and hyper-sensitivity. There is limited data prospectively assessing cranial and extra-cranial autonomic symptoms with a validated instrument, or longitudinal data on the relationship between migraine disease activity and autonomic symptoms. Methods: Patients attending a single tertiary academic center were recruited into a prospective cohort study between September 2020 and June 2022. In addition to standard clinical care, they completed several surveys including the Composite Autonomic Symptom Scale (COMPASS-31) questionnaire, a validated survey of autonomic symptoms. Results: A total of 43 patients (66.7% female, median age 42, IQR 17) were included in the final analysis. There was a baseline 20 monthly headache days (MHD) (IQR 21.7), and 65.1% of the population had chronic migraine by ICHD-3 criteria. A significantly elevated weighted COMPASS-31 score was reported in 60.5% of respondents (mean 30.3, SD 13.3) at baseline. After 12 months treatment, significant improvements were reported in migraine frequency (median MHD 20–8.7) and disability (median Migraine Disability Assessment Score 67–48), but not in autonomic symptoms (mean score 30.3, SD 11.2). Conclusion: Autonomic symptoms were frequently reported in patients with migraine. However, they did not correlate with headache frequency or reversion to episodic frequency. Further study is required to elucidate specific approaches and treatments for autonomic symptoms, and further evaluate the underlying pathophysiological mechanisms.

neurosciences,clinical neurology
Migraine May Represent an Independent Risk Factor for Retinal Stroke: A Population-Based Cohort Study

Jay B Lusk,Ailin Song,Shakthi Unnithan,Hussein R Al-Khalidi,Adam de Havenon,Valérie Biousse,Matthew Schrag,Elena Solopova,Sven Poli,Nosayaba Osazuwa-Peters,Ying Xian,Emily O'Brien,Brian Mac Grory

DOI: https://doi.org/10.1016/j.clineuro.2024.108587

Abstract:Introduction: Migraine is an established risk factor for cerebral ischemic stroke, with an especially robust association in patients with migraine with aura. However, it is not known if migraine is a risk factor for retinal stroke (central or branch retinal artery occlusion; CRAO or BRAO). Methods: We performed a retrospective, observational, cohort study using population-based data from the State Inpatient Databases and State Emergency Department Databases from New York (2006-2015), California (2003-2011), and Florida (2006-2015) to determine the association between hospital-documented migraine and retinal stroke. The primary exposure was hospital-documented migraine (ascertained from admission or emergency department diagnosis codes). The primary endpoint was time to hospital-documented CRAO (ICD-9-CM code 362.31 in the primary diagnosis position) and secondary endpoints included time to BRAO and any retinal artery occlusion (RAO). Cause-specific hazard models were used to model the association between migraine and subsequent CRAO. Results: Of 39,835,024 patients included in the study, 1109,140 had migraine documented during our two year ascertainment window. Patients with migraine were younger (40.2±15.2 vs. 46.9±19.8, standardized difference (SD) 0.38), more likely to be female (81.4 % vs. 54.7 %, SD 0.6), and had a lower burden of atrial fibrillation (4.5 % vs. 6.9 %, SD 0.1), chronic kidney disease (1.9 % vs. 3.6 %, SD 0.2), and congestive cardiac failure (2.7 % vs. 5.1 %, SD 0.12). Migraine was not associated with CRAO in the primary diagnostic position (adjusted hazard rate (aHR) 1.15 (95 % CI: 0.79-1.67). However, it was associated with CRAO in any diagnostic position (aHR 1.39 (95 % CI: 1.08-1.78). As positive controls, we replicated previously established associations of migraine with cerebral ischemic stroke (aHR 1.35 (95 % CI: 1.32-1.38) and embolic ischemic stroke (aHR 1.15 (95 % CI: 1.08-1.22). Conclusions: In a large, nationally-representative, claims-based study of patients from 3 regions in the United States (US), we did not find an adjusted association between migraine and a primary discharge diagnosis of CRAO. Our hypothesis-generating finding that migraine was associated with CRAO when using a broader definition sets the stage for future work leveraging both outpatient and pharmacy based claims to further explore this finding.
Abstract WP241: Migraine Associated Risk of Stroke Score

Caylee McCain,Michael Parrish,Wayne D Rosamond,Sweta Sengupta,Francis G Spinale,Souvik Sen

DOI: https://doi.org/10.1161/str.55.suppl_1.wp241

IF: 10.17

2024-02-03

Stroke

Abstract:Stroke, Volume 55, Issue Suppl_1, Page AWP241-AWP241, February 1, 2024. Background:Migraine with aura is a risk factor for ischemic stroke. We refined the migraine with aura risk score (MARS) to create the migraine associated risk of stroke score (MARS Plus) making it applicable to migraine with and without aura. The expanded risk score includes vascular risk factors, migraine characteristics, and medications used in migraine patients.Methods:We prospectively evaluated participants in Atherosclerosis Risk in Communities Cohort (ARIC) with history of migraine. In this population, we tested the association of potential risk factors for ischemic stroke using a Cox proportional-hazards model. The coefficient of each variable was divided by the lowest β value and rounded to the nearest integer. The sum of the weighted score of the reported risk factors was found and was categorized into two prognostic groups.Results:We assessed migraine characteristics (aura, migraine frequency and duration) and medications (ergot alkaloids, triptans, hormone replacement therapy, sympathomimetics and steroids) in addition to traditional risk factors. Based on the points derived from the significant factors we assigned age≥65 =2, non-white race=2, hypertension=3, diabetes=4, body mass index ≥30 =2, coronary artery disease =2, atrial fibrillation =3, alcohol use=1, steroids=3 and presence of aura=2 to total 24 points. Cut-off of MARS Plus ≥5 was considered high risk for ischemic stroke based on receiver operating characteristic (ROC) curve and Youden's index (Figure). Of the 1485 migraineurs, 112 had an ischemic stroke. MARS Plus ≥5 revealed a hazard ratio of 4.29 (95% CI 2.86-6.45) as shown in the Kaplan-Meier Survival Curve.Conclusion:The new MARS Plus is used to predict ischemic stroke in patients with migraine with and without aura. This new risk score, in addition to generalizability, includes factors such as migraine characteristics and medications that may increase stroke risk.

peripheral vascular disease,clinical neurology
Anxiety and depression and health-related quality of life among adults with migraine: a National Population-Based Study

Monira Alwhaibi,Bander Balkhi,Yazed AlRuthia

DOI: https://doi.org/10.3389/fpubh.2023.1241800

2023-10-04

Abstract:Background: Adults who suffer from migraines are highly susceptible to mental illnesses that may have significant association with their HRQoL. Therefore, this study aimed to investigate how anxiety and depression related to HRQoL in adults with Migraine. Methods: Data from the Medical Expenditure Panel Survey for 2017 to 2020 were used to identify adult patients 18 years of age and older with a migraine diagnosis. The Physical and Mental Component Summary (PCS & MCS) scores from the SF-12 were used to calculate HRQoL. To adjust for a wide range of variables, multivariate linear regressions were used to evaluate the association between depression and anxiety and HRQoL among adults with migraine. Results: Among the 1,713 identified adults with migraines, 11.2% experienced depression, 14.6% experienced anxiety, and 13.7% had both conditions. Compared to migraineurs who had only migraine, adults with comorbid depression and anxiety had the lowest mean scores on the PCS and MCS. Additionally, migraineurs who had depression had significantly lower HRQoL MCS scores (depression: β = -7.552, p < 0.001), and those with anxiety had significantly lower HRQoL MCS scores (anxiety: β = -4.844, p < 0.001) compared to those without these comorbidities. Notably, individuals with migraines who exercise had higher scores on both PCS and MCS than those who did not exercise. Conclusion: This nationally representative sample provides insights into the associations between depression and anxiety with poor HRQoL among individuals with migraines. Additionally, it revealed the negative impact of concurrent chronic diseases, and poor socioeconomic status on HRQoL, while emphasizing the beneficial effects of regular exercise. This study highlights the clinical, policy, and public health implications for improving healthcare planning, resource allocation, and promoting lifestyle changes to reduce depression and anxiety in migraine sufferers.
Cohort profile: migraine exposures and cardiovascular health in Hong Kong Chinese women (MECH-HK)

Qingling Yang,Qi Sun,Alice Yuen Loke,Chun Hao,Harry Haoxiang Wang,Jing Qin,Lin Yang,Yao Jie Xie

DOI: https://doi.org/10.1136/bmjopen-2024-084228

IF: 3.006

2024-07-16

BMJ Open

Abstract:Purpose: Evidence about the associations of migraine features with cardiovascular risk profiles in Chinese population is lacking. The Migraine Exposures and Cardiovascular Health in Hong Kong Chinese Women (MECH-HK) cohort was constructed to investigate longitudinal migraine features and their cardiovascular implications in Hong Kong Chinese women. Participants: We enrolled 4221 Hong Kong Chinese women aged 30 years or above from October 2019 to December 2020. Demographics, reproductive information, lifestyle factors, disease history, blood lipids and glucose, anthropometrics and body compositions were measured during baseline and follow-up. Migraine diagnosis followed the International Classification of Headache Disorders-3 criteria. Migraine features were longitudinally tracked using a migraine diary and summarised by a wide range of epidemiological metrics. Cardiovascular health was assessed using the Framingham risk score (FRS). Findings to date: From October 2021 to June 2023, 3455 women completed the first follow-up measurement. The retention rate was 81.9%. The average age at baseline was 54.40 years. The mean blood glucose, high-density lipoprotein cholesterol and low-density lipoprotein cholesterol levels were 6.44 mmol/L, 65.06 mg/dL and 102.40 mg/dL, respectively. The average FRS was 0.06. Participants had a 10.3% prevalence of migraine or probable migraine. After 1.27 years of follow-up, the median migraine attack frequency was 0.99 attacks/month, with an incidence rate of 2.55 attacks/person-month and a median duration of 7.70 hours/attack. Sleep problems (64.7%) and stress (54.0%) were the top triggers, while prevalent accompanying symptoms were nausea (67.4%), photophobia (39.9%), phonophobia (30.0%) and vomiting (26.2%). Migraine auras included blurred visions (59.6%), flashing lights (41.3%), blind spots (33.0%), pins and needles (6.4%) and halo (1.8%). Future plans: The follow-up for the cohort will be implemented every 2 years. MECH-HK will provide unique longitudinal data on migraine features in Hong Kong women. The linkage between migraine features and cardiovascular disease risk progression will be identified by a long-term observation.
Migraine Prevalence, Environmental Risk, and Comorbidities in Men and Women Veterans

Marianna Gasperi,Nathaniel M Schuster,Brooke Franklin,Caroline M Nievergelt,Murray B Stein,Niloofar Afari,Nathaniel M. Schuster,Caroline M. Nievergelt,Murray B. Stein

DOI: https://doi.org/10.1001/jamanetworkopen.2024.2299

2024-03-15

JAMA Network Open

Abstract:Importance Migraine is a prevalent and debilitating condition that substantially impacts quality of life. Investigating migraine prevalence, associated comorbidities, and potential military service exposures in veterans, focusing on gender differences, is crucial for targeted interventions and management strategies. Objective To determine the prevalence of migraine, associated health comorbidities, and potential military service and environmental exposures among men and women US veterans using a large-scale epidemiological sample from the Million Veteran Program (MVP). Design, Setting, and Participants This cross-sectional study analyzed self-report survey data from the MVP, a large epidemiological sample of US veterans that was started in 2011 and has ongoing enrollment. Eligible participants were selected from the MVP database in 2023. The study included 491 604 veterans to examine migraine prevalence, health comorbidities, demographic characteristics, military service history, and environmental exposures. Data were analyzed from December 2022 to July 2023. Exposures Military service and environmental factors, such as chemical or biological warfare exposure, were considered. Main Outcomes and Measures The primary outcome was migraine prevalence among men and women veterans, assessed through self-reported diagnoses. Secondary outcomes included the association between migraine and health comorbidities, demographic characteristics, military service history, and environmental exposures. Results Of the 491 604 veterans included in this study, 450 625 (91.8%) were men and 40 979 (8.2%) were women. The lifetime prevalence of migraine was significantly higher in women (12 324 of 40 979 [30.1%]) than in men (36 816 of 450 625 [8.2%]). Migraine prevalence varied by race and ethnicity, with the highest prevalence in Hispanic or Latinx women (1213 of 3495 [34.7%]). Veterans with migraine reported worse general health, higher levels of pain, increased pain interference with work, a higher likelihood of psychiatric and neurological health conditions, and greater lifetime opioid use. Specific aspects of military service, including service post-September 2001 and deployment in Operation Enduring Freedom and Operation Iraqi Freedom, and environmental factors, including Agent Orange, chemical and biological welfare, and antinerve agent pills history, were significantly associated with migraine prevalence. Conclusions and Relevance In this cross-sectional study of migraine, the results highlighted gender differences in migraine prevalence and associated health comorbidities among US veterans. The findings emphasized the need for interdisciplinary approaches to migraine management, increased awareness and education efforts, and population-based screening strategies, particularly for women and Hispanic veterans who are at greater risk. Our findings encourage further research into tailored interventions for specific subpopulations and the impact of military service and environmental exposures on migraine and related health conditions.

medicine, general & internal
Vascular Risk Factors and Biomarkers of Endothelial Dysfunction in Chronic Migraine patients- A Cross-sectional Study

Hari Nath Yadav,Sanjay Rao Kordcal,Manju Yadav,Bhawna Mahajan,Ashish Kumar Duggal,Poonam Narang,Meenakshi Thakkar,Debashish Chowdhury

DOI: https://doi.org/10.7860/jcdr/2023/64173.18431

2023-01-01

JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH

Abstract:Introduction: The available literature on vascular risk and endothelial dysfunction in patients with Chronic Migraine (CM) is limited. CM patients are known to have a higher risk of cardiovascular and cerebrovascular events. The present study aims to characterise the vascular risk and endothelial dysfunctions in CM patients and compare them with Healthy Controls (HC). Aim: To assess the vascular risk factors and biomarkers of endothelial dysfunction in CM patients and compare them with healthy non-headache controls. Materials and Methods: This cross-sectional study was conducted from October 2021 to January 2023 at the headache clinic of GB Pant Institute of Postgraduate Medical Education and Research in Delhi, India. The patients were diagnosed with CM using the International Classification of Headache Disorders-3 (ICHD-3) criteria. The patients were drug-naïve for preventive medications and did not have medication overuse headache. Clinical vascular risk factors such as Systolic Blood Pressure (SBP), Diastolic Blood Pressure (DBP), Ankle Brachial Index (ABI), Body Mass Index (BMI), and Waist Hip Ratio (WHR) were measured. A battery of biochemical vascular risk factors, including serum C-reactive protein, leptin, insulin, fasting and post-prandial glucose, Glycosylated Haemoglobin (HbA1c), lipid profile, lipoprotein-A, pro-Brain Natriuretic Peptide (proBNP), and serum biomarkers of endothelial dysfunction like Intercellular Adhesion Molecules-1 (ICAM-1), Myeloperoxidase (MPO), Interleukin-6 (IL-6), Tumour Necrosis Factor-Alpha (TNFalpha), Asymmetric Dimethyl Arginine (ADMA), fibrinogen, and von Willebrand’s factor were measured in all patients during the interictal period. Statistical analysis was done using the Statistical Package for Social Sciences (SPSS) version 25.0, and the Mann-Whitney U test, student’s t-test, and Chi-square tests were applied. Results: Thirty-two patients with CM and thirty-two nonheadache healthy subjects were included in the study (age 30.6±8.8 years; 29 females and 3 males) vs. (31.7±7.9 years; 19 females and 13 males, respectively). Compared to HC, CM patients had significantly higher DBP (81.0±8.0 mmHg vs. 66.2±6.2 mmHg; p<0.001). Among the biochemical parameters, CM patients had higher post-prandial blood sugar (mg/dL) (140.2±10.7 vs. 136.6±7.0; p=0.021), HbA1c (%) (5.8±0.8 vs. 5.6±0.4; p=0.034), serum cholesterol (mg/dL) (146.9±36.2 vs. 131±20.8), and Triglyceride (TG) levels (mg/dL) (93.2±10.8 vs. 88.5±13.0; p=0.001) compared to HCs. Among the biomarkers of endothelial dysfunction studied, levels of ICAM-1 (pg/mL) (4.5±3.8 vs. 1.3±0.62; p<0.001), MPO (pg/mL) (415.4±266.0 vs. 108.9±141.4; p=0.001), IL-6 (pg/mL) (10.8±4.9 vs. 4.2±1.5; p<0.001), and ADMA (ng/mL) (32.6±28.3 vs. 23.5±22.1; p=0.008) were higher in the CM group compared to non-headache controls. Conclusion: This study found that patients with CM have significantly higher vascular risk and evidence of endothelial dysfunction compared to healthy non-headache controls. The significantly elevated biomarkers of endothelial dysfunction may possibly be related to persistent neurogenic inflammation in CM and require further exploration through larger studies.
Multinary Selenides with Unusual Coordination Environment of

M. Chung,Chi‐Shen Lee

Abstract:New multinary selenides Ae3SnPn2Se8 (Ae = Sr, Ba; Pn = Sb, Bi), Sr8.01Ge2.04Bi7.95Se24, and Sr8YGe2Bi7Se24 were synthesized by solid-state reaction, and their structures were determined by single-crystal X-ray diffraction. These compounds crystallize in orthorhombic space group Pnma (no. 62) for Ae3SnPn2Se8 (Ae = Sr, Ba; Pn = Sb, Bi) and in Pna21 (no. 33) for Sr8.01Ge2.04Bi7.95Se24 and Sr8YGe2Bi7Se24. The structures feature one-dimensional corner sharing tetrahedral ∞ 1 [MSe3] units, and one-dimensional edge sharing octahedral ∞ 1 [M4Se10], packed with the alkaline earth or rare earth cations. Sr8.01Ge2.04Bi7.95Se24 and Sr8YGe2Bi7Se24 contain a triple cell superlattice structure derived from a special arrangement of Bi and Ge in the tetrahedrally coordinated ∞ 1 [MSe3] chain. Diffuse reflectance spectra and electronic resistivity measurements indicate semiconducting behaviors; the Sr8YGe2Bi7Se24 Seebeck coefficient is −180 μV/K at 303 K. Electronic structure calculations confirm that the electron count for Sr8YGe2Bi7Se24 is optimal for interatomic bonding in the ionic network.
SEX DIFFERENCES IN A CARDIOVASCULAR DISEASE RISK SCORE AND ITS COMPONENTS AS PREDICTORS FOR MULTIMORBIDITY IN THE UK BIOBANK

Katie Harris,Wendy Wang,Cheryl Carcel,Sanne Peters,Mark Woodward,John Chalmers

DOI: https://doi.org/10.1097/01.hjh.0001019528.95521.38

IF: 4.9

2024-05-01

Journal of Hypertension

Abstract:Objective: This study will examine sex differences in the association of a cardiovascular disease risk score and its components (age, treated or untreated systolic BP, total and HDL cholesterol, diabetes and smoking) with cardiovascular and other outcomes (myocardial infarction (MI), stroke, dementia, ESKD, death and multimorbidity). Design and method: This study uses the UK Biobank - a prospective population-based cohort study, that recruited over 500,000 (aged 40 to 69 years) women and men between 2006 and 2010, with continuing follow up for outcomes. The Pooled Cohort Risk Equation, designed to estimate 10-year atherosclerotic cardiovascular disease (ASCVD) risk, was applied to predict 10-year risk of MI, stroke, dementia, ESKD and multimorbidity. Participants with any of these diseases at baseline were excluded from these analyses. Cox regression models were used to model the sex specific association (hazard ratio (HR) with 95% confidence interval (CI)) of the ASCVD risk score and each of the components separately with outcomes. C-statistics were used to determine the predictive ability of the ASCVD risk score compared with the individual components on outcomes. Results: There were 355,466 UK Biobank participants (55% women) eligible for inclusion in these analyses. Compared with having an ASCVD risk score 7.5% (intermediate – high risk) was higher in women (HR 2.60; 95%CI (2.52, 2.69)) than men (2.17 (2.08, 2.27)). Corresponding results were 7.08 (6.13, 8.18) and 4.01 (3.54, 4.54) for MI; 3.53 (3.04, 4.41) and 2.69 (2.24, 3.22) for stroke. The corresponding risks for dementia, ESKD and death were also higher in women than men. ASCVD risk score was a better predictor of multimorbidity than each of the separate individual components, for women and men. This finding held for all other outcomes apart from dementia where age yielded the highest c-statistics. Conclusions: Utilisation of cardiovascular risk scores may provide utility in predicting other diseases individually and in combination (multimorbidity). Clinicians should also be cognisant of a higher risk of events in women compared to men with comparable ASCVD risk scores.

peripheral vascular disease
Migraine and risk of atrial fibrillation: A 9-year follow-up based on the Trøndelag Health Study

Samita Giri,Erling Tronvik,Håvard Dalen,Hanne Ellekjær,Jan P Loennechen,Alexander Olsen,Knut Hagen

DOI: https://doi.org/10.1177/03331024241254517

2024-05-30

Cephalalgia

Abstract:Cephalalgia, Volume 44, Issue 5, May 2024. BackgroundData from some population-based studies have indicated an increased risk of atrial fibrillation (AF) among patients with migraine, particularly among individuals with migraine with aura. The present study aimed to assess the association between primary headache disorders and AF.MethodsIn a population-based 9-year follow-up design, we evaluated the questionnaire-based headache diagnosis, migraine and tension-type headache (TTH) included, collected in the Trøndelag Health Study (HUNT3) conducted in 2006–2008, and the subsequent risk of AF in the period until December 2015. The population at risk consisted of 39,340 individuals ≥20 years without AF at HUNT3 baseline who answered headache questionnaire during HUNT3. The prospective association was evaluated by multivariable Cox proportional hazard models with 95% confidence intervals (CIs).ResultsAmong the 39,340 participants, 1524 (3.8%) developed AF during the 9-year follow up, whereof 91% of these were ≥55 years. In the multivariable analyses, adjusting for known confounders, we did not find any association between migraine or TTH and risk of AF. The adjusted hazard ratios (HRs) were respectively 0.84 (95% CI = 0.64–1.11) for migraine, 1.16 (95% CI = 0.86–1.27) for TTH and 1.04 (95% CI = 0.86–1.27) for unclassified headache. However, in sensitivity analyses of individuals aged ≥55 years, a lower risk of AF was found for migraine (HR = 0.53; 95% CI = 0.39–0.73).ConclusionsIn this large population-based study, no increased risk of AF was found among individuals with migraine or TTH at baseline. Indeed, among individuals aged ≥55 years, migraine was associated with a lower risk for AF.

neurosciences,clinical neurology
Associations between Cerebrovascular Function and the Expression of Genes Related to Endothelial Function in Hormonal Migraine

Jemima S. A. Dzator,Robert A. Smith,Kirsten G. Coupland,Peter R. C. Howe,Lyn R. Griffiths

DOI: https://doi.org/10.3390/ijms25031694

IF: 5.6

2024-01-31

International Journal of Molecular Sciences

Abstract:There is evidence to suggest that hormonal migraine is associated with altered cerebrovascular function. We aimed to investigate whether the expression of genes related to endothelial function in venous blood (1) might influence cerebrovascular function, (2) differs between hormonal migraineur and non-migraineur women, and (3) changes following resveratrol supplementation. This study utilised data obtained from 87 women (59 hormonal migraineurs and 28 controls) where RNA from venous blood was used to quantify gene expression and transcranial Doppler ultrasound was used to evaluate cerebrovascular function. Spearman's correlation analyses were performed between gene expression, cerebrovascular function, and migraine-related disability. We compared the expression of genes associated with endothelial function between migraineurs and non-migraineurs, and between resveratrol and placebo. The expression of several genes related to endothelial function was associated with alterations in cerebrovascular function. Notably, the expression of CALCA was associated with increased neurovascular coupling capacity (p = 0.013), and both CALCA (p = 0.035) and VEGF (p = 0.014) expression were associated with increased cerebral blood flow velocity in the overall study population. Additionally, VCAM1 expression correlated with decreased pulsatility index (a measure of cerebral arterial stiffness) (p = 0.009) and headache impact test-6 scores (p = 0.007) in the migraineurs. No significant differences in gene expression were observed between migraineurs and controls, or between placebo and resveratrol treatments in migraineurs. Thus, altering the expression of genes related to endothelial function may improve cerebrovascular function and decrease migraine-related disability.

biochemistry & molecular biology,chemistry, multidisciplinary
Prospective early adulthood risk factors for vasomotor symptoms in the Coronary Artery Risk Development in Young Adults study

Catherine Kim,Abbi Lane,Thanh-Huyen T Vu,Cora B Lewis,Zhe Yin,Hui Jiang,Richard J Auchus,Pamela J Schreiner

DOI: https://doi.org/10.1097/GME.0000000000002306

2024-02-01

Menopause

Abstract:Objective: Previous studies have assessed potential risk factors for vasomotor symptoms (VMS) beginning in midlife. We examined whether early adulthood risk factors predict VMS trajectories over time. Methods: We performed a secondary data analysis of the Coronary Artery Risk Development in Young Adults (CARDIA) study, a population-based cohort. We included women who answered questions about VMS at three or more examinations (n = 1,966). We examined whether risk factors at baseline (when participants were aged 18-30 y; average age, 25 y) and the year 15 (Y15) exam (at ages 33-45 y; average age, 40 y) were associated with VMS trajectories from Y15 through Y35. Logistic regression models were used to evaluate the associations with VMS trajectories. Results: We identified three trajectories of VMS presence: minimal (40%), increasing over time (27%), and persistent (33%). Baseline factors associated with persistent VMS over time included Black race, less than a high school education, depressive symptoms, migraines, cigarette use, and at Y15 hysterectomy. Baseline factors associated with increasing VMS over time included Black race and lower body mass index. Risk factors for bothersome VMS were similar and also included thyroid disease, although thyroid disease was not associated with persistence of VMS over time. Associations were similar among women who had not undergone hysterectomy and in Black and White women. Conclusions: Risk factors for VMS may be identified in early adulthood. Further examination of risk factors such as migraines and depressive symptoms in early adulthood may be helpful in identifying therapies for VMS.

Detection of induced resistance to cytosine-arabinoside with a short-term test.

Association Between Migraine or Severe Headache and Hypertension among US Adults: A Cross-Sectional Study

Risk for Ischemic Stroke and Coronary Heart Disease Associated with Migraine and Migraine Medication among Older Adults

Frontometaphyseal dysplasia: symptoms and possible mode of inheritance.

Cerebrovascular Function in Hormonal Migraine: An Exploratory Study

Effects of different endurance exercise modalities on migraine days and cerebrovascular health in episodic migraineurs: A randomized controlled trial

Association of Migraine With Incident Hypertension After Menopause: A Longitudinal Cohort Study

Abstract WP252: MARS: Migraine and Retinal Stroke - A Population-Based Cohort Study of 39 Million Patients

Migraine and Risk of Parkinson Disease in Women: A Cohort Study

Autonomic symptoms in migraine: Results of a prospective longitudinal study

Migraine May Represent an Independent Risk Factor for Retinal Stroke: A Population-Based Cohort Study

Abstract WP241: Migraine Associated Risk of Stroke Score

Anxiety and depression and health-related quality of life among adults with migraine: a National Population-Based Study

Cohort profile: migraine exposures and cardiovascular health in Hong Kong Chinese women (MECH-HK)

Migraine Prevalence, Environmental Risk, and Comorbidities in Men and Women Veterans

Vascular Risk Factors and Biomarkers of Endothelial Dysfunction in Chronic Migraine patients- A Cross-sectional Study

Multinary Selenides with Unusual Coordination Environment of

SEX DIFFERENCES IN A CARDIOVASCULAR DISEASE RISK SCORE AND ITS COMPONENTS AS PREDICTORS FOR MULTIMORBIDITY IN THE UK BIOBANK

Migraine and risk of atrial fibrillation: A 9-year follow-up based on the Trøndelag Health Study

Associations between Cerebrovascular Function and the Expression of Genes Related to Endothelial Function in Hormonal Migraine

Prospective early adulthood risk factors for vasomotor symptoms in the Coronary Artery Risk Development in Young Adults study